These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8346720)

  • 1. Molecular approaches to cancer therapy.
    Israel MA
    Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development of antisense oligonucleotides as anti-cancer therapeutics.
    Chen HX
    Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent status of the antisense oligonucleotide approaches in oncology.
    Ma L; Calvo F
    Fundam Clin Pharmacol; 1996; 10(2):97-115. PubMed ID: 8737953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides and the rational design of new antitumor drugs.
    Prieto J; Hernández-Alcoceba R
    Rev Esp Enferm Dig; 2005 Jul; 97(7):467-71. PubMed ID: 16262525
    [No Abstract]   [Full Text] [Related]  

  • 5. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogenes and pharmacological approaches to cancer therapy].
    Tocque B
    Pathol Biol (Paris); 1992 Nov; 39(9):869-70. PubMed ID: 1538914
    [No Abstract]   [Full Text] [Related]  

  • 9. 10 years and counting: the hype and hope of cancer biotechnology.
    Morris K
    Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706
    [No Abstract]   [Full Text] [Related]  

  • 10. Antisense anticancer oligonucleotide therapeutics.
    Wang H; Prasad G; Buolamwini JK; Zhang R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):177-96. PubMed ID: 12188878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-modified cells for the treatment of cancer.
    Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM
    Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization by antisense oligonucleotides targeting MDM2.
    Bianco R; Ciardiello F; Tortora G
    Curr Cancer Drug Targets; 2005 Feb; 5(1):51-6. PubMed ID: 15720189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic targeting of tumor suppressor genes.
    Morris LG; Chan TA
    Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies of antisense oligonucleotides for cancer therapy.
    Orr RM; Dorr FA
    Methods Mol Med; 2005; 106():85-111. PubMed ID: 15375314
    [No Abstract]   [Full Text] [Related]  

  • 19. Oligonucleotide therapeutics: a step forward.
    Gewirtz AM
    J Clin Oncol; 2000 May; 18(9):1809-11. PubMed ID: 10784620
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploiting genetic alterations to design novel therapies for cancer.
    Cripe TP; Mackall CL
    Hematol Oncol Clin North Am; 2001 Aug; 15(4):657-75, viii. PubMed ID: 11676278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.